Cite Filings / GANX / 0001104659-22-063887
Feed Companies Filings Check
Sign in
S-3/A

Registration Statement

Gain Therapeutics, Inc. · Filed 2022-05-23 · Acc 0001104659-22-063887

Documents 1

  • S-3/A Registration Statement , tm2215771d3_s3a.htm

Around this filing

  • 2025-11-07 S-3/A Registration Statement
  • 2022-05-27 4 CHIEF EXECUTIVE OFFICER bought 2,482 shares at $2.58 ($6,404)
  • 2022-05-23 4 CHIEF EXECUTIVE OFFICER bought 13,256 shares at an average $2.79 ($37,034)
  • 2022-05-23 4/A CHIEF FINANCIAL OFFICER bought 3,000 shares at $2.70 ($8,100)
  • 2022-05-23 S-3/A Registration Statement
  • 2022-05-20 UPLOAD SEC-generated Letter
  • 2022-05-19 4 CHIEF FINANCIAL OFFICER bought 3,000 shares at $8,100.00 ($24,300,000)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading tm2215771d3_s3a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…